Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: Relation to reduced prenatal growth

Pediatric Research

Volumn 46, Issue 3, 1999, Pages 320-322

  Ibáñez, Lourdes ^b   Potau, Neus ^b   De Zegher, Francis ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID; LIPOPROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; CHILD; DYSLIPIDEMIA; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENARCHE; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 0345281580     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199909000-00012     Document Type: Article

References (33)

1. Barker DJ 1998 Mothers, Babies and Diseases in Later Life. Churchill Livingstone, London
2. Ibáñez L, Potau N, Carrascosa A 1997 Androgens in adrenarche and pubarche. In: Azziz R, Nestler JE, Dewailly D (eds) Androgen Excess in Women. Lippincott-Raven Publishers, Philadelphia, pp 73-84
3. Francois I, de Zegher F 1997 Adrenarche and fetal growth. Pediatr Res 41:440-442
4. Ibáñez L, Potau N, Francois I, de Zegher F 1998 Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83:3558-3662
5. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A 1997 Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 82:2283-2288
6. Ibáñez L, Potau N, Chacón P, Pascual C, Carrascosa A 1998 Hyperinsulinemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 41:1057-1063
7. Marshall WA, Tanner JM 1969 Variations in the pattern of pubertal changes in girls. Arch Dis Child 44:291-303
8. Rosenfield RL 1971 Plasma 17-ketosteroids and 17β-ketosteroids in girls with premature development of sexual hair. J Pediatr 79:260-266
9. Rosenfield RL 1994 Normal and almost normal precocious variations in pubertal development: premature pubarche and premature thelarche revisited. Horm Res 41(suppl 2):7-13
10. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS 1983 Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 56:320-325
11. 5-steroid levels. J Clin Endocrinol Metab 81:3961-3965
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
13. 2. Clin Chem 29:2026-2030
14. Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, Mowery R, Tamir I, Rifkind B 1980 Plasma cholesterol and triglyceride distributions in 13665 children and adolescents: the prevalence study of the Lipid Research Clinics Program. Pediatr Res 14:194-202
15. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS 1993 Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67
16. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD 1997 Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 82:402-406
17. de Zegher F, Francois I, van Helvoirt M, Van de Berghe G 1997 Small as a fetus and short as a child: from endogenous to exogenous growth hormone. J Clin Endocrinol Metab 82:2021-2026
18. de Zegher F, Francois I, Ibáñez L 1999 Pediatric endocrinopathies related to reduced fetal growth. Growth Genet Horm 15:1-5
19. Ibáñez L, Potau N, de Zegher F 1999 Anovulation after precocious pubarche: early markers and time course in adolescence. J Clin Endocrinol Metab (in press)
20. Francois I, de Zegher F, Spiessens C, D'Hooghe T, Vanderschueren D 1997 Low birth weight and subsequent male subfertility. Pediatr Res 42:899-901
21. Lee PDK, Jensen MD, Divertie GD, Heiling VJ, Katz HH, Conover CA 1993 Insulin-like growth factor binding protein-1 response to insulin during suppression of endogenous insulin secretion. Metabolism 42:409-414
22. Ibáñez L, Potau N, Carrascosa A 1998 Insulin resistance, premature adrenarche, and a risk of the polycystic ovary syndrome (POS). Trends Endocrinol Metab 9:72-77
23. Yki-Järvinen H, Makimattila S, Utrianen T, Rutanen E 1995 Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone binding-globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 80:3227-3232
24. Travers S, Labarta JI, Gargosky SE, Rosenfeld RG, Jeffers BW, Eckel RH 1998 Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early prepubertal children. J Clin Endocrinol Metab 83:1935-1939
25. Fall CHD, Pandit AN, Law CM, Yajnik CS, Clark PM, Breier B, Osmond C, Shiell AW, Gluckman PD, Barker DJ 1995 Size at birth and plasma insulin-like growth factor-1 concentrations. Arch Dis Child 73:287-293
26. Langford K, Blum W, Nicolaides K, Jones J, McGregor A, Miell J 1994 The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by undernutrition? Eur J Clin Invest 24:851-856
27. Newman III WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS 1986 Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. N Engl J Med 314:138-143
28. Patsch JR, Miesenböck G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto Jr AM, Patsch W 1992 Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 12:1336-1345
29. Ferrannini E, Haffner SM, Mitchell BD, Stern MP 1991 Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422
30. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL 1983 Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118:326-337
31. Després JP 1993 The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease? Can Med Assoc J 148:1339-1340
32. Rönnemaa T, Knip M, Lautala P, Viikari J, Uhari M, Leino A, Kaprio EA, Salo MK, Dahl M, Nuutinen EM 1991 Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med 23:67-72
33. Arslanian S, Suprasongsin C 1996 Insulin sensitivity, lipids and body composition in childhood: is "syndrome X" present? J Clin Endocrinol Metab 81:1058-1062